Ticker	Volume	Price	Price Delta
DJIA	15,307.20	-80.41	-0.52%
S&P 500	1,655.35	-13.81	-0.83%
Nasdaq	3,463.30	-38.82	-1.11%

Ticker

Volume

Price

Price Delta

DJIA

15,307.20

-80.41

-0.52%

S&P 500

1,655.35

-13.81

-0.83%

Nasdaq

3,463.30

-38.82

-1.11%

Ticker	Volume	Price	Price Delta
STOXX 50	2,835.01	+13.36	0.47%
FTSE 100	6,840.27	+36.40	0.53%
DAX	8,530.89	+58.69	0.69%

Ticker

Volume

Price

Price Delta

STOXX 50

2,835.01

+13.36

0.47%

FTSE 100

6,840.27

+36.40

0.53%

DAX

8,530.89

+58.69

0.69%

Ticker	Volume	Price	Price Delta
Nikkei	14,484.00	-1,143.28	-7.32%
Hang Seng	22,734.70	-526.35	-2.26%
S&P/ASX 200	5,062.40	-102.97	-1.99%

Ticker

Volume

Price

Price Delta

Nikkei

14,484.00

-1,143.28

-7.32%

Hang Seng

22,734.70

-526.35

-2.26%

S&P/ASX 200

5,062.40

-102.97

-1.99%

Hunt Says AgeLOC Has Been a `Blockbuster' for Nu Skin: Video

2010-08-10T23:05:35Z

Truman Hunt, chief executive officer at Nu Skin Enterprises Inc., discusses the outlook for his company and business growth.

Hunt speaks with Pimm Fox on Bloomberg Television's "Taking Stock" from the Canaccord Global Growth Conference. (Source: Bloomberg)

Running time 06:30

Nu Skin's Hunt Interview About Business Strategy

Aug. 10 (Bloomberg) -- Truman Hunt, chief executive officer at Nu Skin Enterprises Inc., discusses the outlook for his company and business growth. Hunt speaks with Pimm Fox on Bloomberg Television's "Taking Stock" from the Canaccord Global Growth Conference. (Source: Bloomberg)

More News:

CEO Spotlight

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.